Oxidative status and acute phase reactants in patients with environmental asbestos exposure and mesothelioma

The Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Sezgi, Cengizhan ^a   Taylan, Mahsuk ^a   Selimoglu Sen, Hadice ^a   Evliyaoǧlu, Osman ^a   Kaya, Halide ^a   Abakay, Ozlem ^a   Abakay, Abdurrahman ^a   Tanrkulu, Abdullah Cetin ^a   Senyiǧit, Abdurrahman ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ASBESTOS; COPPER; OXIDIZING AGENT; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; CROSS-SECTIONAL STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; LUNG TUMOR; MALE; MESOTHELIOMA; MIDDLE AGED; OXIDATIVE STRESS;

ACUTE-PHASE PROTEINS; ADULT; AGED; ASBESTOS; CASE-CONTROL STUDIES; COPPER; CROSS-SECTIONAL STUDIES; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MESOTHELIOMA; MIDDLE AGED; OXIDANTS; OXIDATIVE STRESS; TUMOR MARKERS, BIOLOGICAL;

EID: 84893830809     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/902748     Document Type: Article

References (31)

1. Mossman B. T., Churg A., Mechanisms in the pathogenesis of asbestosis and silicosis. American Journal of Respiratory and Critical Care Medicine 1998 157 5 1666 1680 2-s2.0-0031799746 10.1164/ajrccm.157.5.9707141
2. Janssen Y. M. W., Marsh J. P., Absher M. P., Hemenway D., Vacek P. M., Leslie K. O., Borm P. J. A., Mossman B. T., Expression of antioxidant enzymes in rat lungs after inhalation of asbestos or silica. The Journal of Biological Chemistry 1992 267 15 10625 10630 2-s2.0-0026658119
3. Sarban S., Kocyigit A., Yazar M., Isikan U. E., Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clinical Biochemistry 2005 38 11 981 986 2-s2.0-27744591295 10.1016/j.clinbiochem.2005.08.003 (Pubitemid 41606795)
4. Blokhina O., Fagerstedt K. V., Oxidative metabolism, ROS and NO under oxygen deprivation. Plant Physiology and Biochemistry 2010 48 5 359 373 2-s2.0-77953152723 10.1016/j.plaphy.2010.01.007
5. Matsuzaki H., Maeda M., Lee S., Nishimura Y., Kumagai-Takei N., Hayashi H., Yamamoto S., Hatayama T., Kojima Y., Tabata R., Kishimoto T., Hiratsuka J., Otsuki T., Asbestos-induced cellular and molecular alteration of immunocompetent cells and their relationship with chronic inflammation and carcinogenesis. Journal of Biomedicine and Biotechnology 2012 2012 9 492608 10.1155/2012/492608
6. Janssen Y. M. W., Marsh J. P., Absher M. P., Gabrielson E., Borm P. J. A., Driscoll K., Mossman B. T., Oxidant stress responses in human pleural mesothelial cells exposed to asbestos. American Journal of Respiratory and Critical Care Medicine 1994 149 3 795 802 2-s2.0-0028343981 (Pubitemid 24082244)
7. Erel O., A new automated colorimetric method for measuring total oxidant status. Clinical Biochemistry 2005 38 12 1103 1111 2-s2.0-29144527533 10.1016/j.clinbiochem.2005.08.008 (Pubitemid 41797751)
8. Coussens L. M., Werb Z., Inflammation and cancer. Nature 2002 420 6917 860 867 2-s2.0-0037180757 10.1038/nature01322 (Pubitemid 36019639)
9. Philip M., Rowley D. A., Schreiber H., Inflammation as a tumor promoter in cancer induction. Seminars in Cancer Biology 2004 14 6 433 439 2-s2.0-5444256371 10.1016/j.semcancer.2004.06.006 (Pubitemid 39360991)
10. Robinson S. C., Coussens L. M., Soluble mediators of inflammation during tumor development. Advances in Cancer Research 2005 93 159 187 2-s2.0-19844373824 10.1016/S0065-230X(05)93005-4 (Pubitemid 41557275)
11. Federico A., Morgillo F., Tuccillo C., Ciardiello F., Loguercio C., Chronic inflammation and oxidative stress in human carcinogenesis. International Journal of Cancer 2007 121 11 2381 2386 2-s2.0-35648946229 10.1002/ijc.23192 (Pubitemid 350022406)
12. Craighead J. E., Abraham J. L., Churg A., Green F. H., Kleinerman J., Pratt P. C., Seemayer T. A., Vallyathan V., Weill H., The pathology of asbestos-associated diseases of the lungs and pleural cavities: diagnostic criteria and proposed grading schema. Report of the Pneumoconiosis Committee of the College of American Pathologists and the National Institute for Occupational Safety and Health. Archives of Pathology and Laboratory Medicine 1982 106 11 544 596 2-s2.0-0020477738
13. Manning C. B., Vallyathan V., Mossman B. T., Diseases caused by asbestos: mechanisms of injury and disease development. International Immunopharmacology 2002 2 2-3 191 200 2-s2.0-0036147411 10.1016/S1567-5769(01)00172-2 (Pubitemid 34075410)
14. Kinnula V. L., Crapo J. D., Superoxide dismutases in the lung and human lung diseases. American Journal of Respiratory and Critical Care Medicine 2003 167 12 1600 1619 2-s2.0-0038545583 10.1164/rccm.200212-1479SO (Pubitemid 36760673)
15. Matsuzaki H., Maeda M., Lee S., Asbestos-induced cellular and molecular alteration of immunocompetent cells and their relationship with chronic inflammation and carcinogenesis. Journal of Biomedicine and Biotechnology 2012 2012 9 492608 10.1155/2012/492608
16. Osada H., Takahashi T., Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer. Oncogene 2002 21 48 7421 7434 2-s2.0-0037152635 10.1038/sj.onc.1205802 (Pubitemid 35305598)
17. Syslová K., Kacer P., Kuzma M., Najmanová V., Fenclová Z., Vlcková S., Lebedová J., Pelclová D., Rapid and easy method for monitoring oxidative stress markers in body fluids of patients with asbestos or silica-induced lung diseases. Journal of Chromatography B 2009 877 24 2477 2486 10.1016/j.jchromb.2009.06.008
18. Tanrikulu A. C., Abakay A., Kaplan M. A., Küçüköner M., Palanci Y., Evliyaoglu O., Sezgi C., Sen H., Carkanat A. I., Kirbas G., A Clinical, radiographic and laboratory evaluation of prognostic factors in 363 patients with malignant pleural mesothelioma. Respiration 2010 80 6 480 487 2-s2.0-78649327372 10.1159/000321370
19. Abu-Youssef H., Amin S., Amin H., Osman E., Value of C-reactive protein in etiologic diagnoss of pleural effusion. The Egyptian Journal of Bronchology 2010 4 124 130
20. Nojiri S., Gemba K., Aoe K., Kato K., Yamaguchi T., Sato T., Kubota K., Kishimoto T., Survival and prognostic factors in malignant pleural mesothelioma: a retrospective study of 314 patients in the west part of Japan. Japanese Journal of Clinical Oncology 2011 41 1 32 39 2-s2.0-78650794570 10.1093/jjco/hyq159
21. Chan E. D., Pott G. B., Silkoff P. E., Ralston A. H., Bryan C. L., Shapiro L., Alpha-1-antitrypsin inhibits nitric oxide production. Journal of leukocyte biology 2012 92 6 1251 1260 10.1189/jlb.0212071
22. Huuskonen M. S., Räsänen J. A., Härkönen H., Asp S., Asbestos exposure as a cause of immunological stimulation. Scandinavian Journal of Respiratory Diseases 1978 59 6 326 332 2-s2.0-0018217639 (Pubitemid 9140437)
23. Kasprzyk M., Dyszkiewicz W., Zwaruń D., Szydlik S., Leśniewska K., Krzyzanowski M., The quantitative evaluation of the serum acute phase proteins (APP) of patients undergoing a curative resection for non-small cell lung cancer (NSCLC). Przegld Lekarski 2006 63 10 936 940 2-s2.0-33947492701
24. Wu C., Chen C., Yang Y., Hao C., Ni J., Che D., Relationship between the expression of alpha 1-antitrypsinase in bronchioalveolar carcinoma and clinical pathology. Journal of Tongji Medical University 2000 20 1 26 28 2-s2.0-0642366560 (Pubitemid 33210412)
25. Yldrm A., Meral M., Kaynar H., Polat H., Uçar E. Y., Relationship between serum levels of some acute-phase proteins and stage of disease and performance status in patients with lung cancer. Medical Science Monitor 2007 13 4 CR195 CR200 2-s2.0-34147180985 (Pubitemid 46557755)
26. Milman N., Pedersen L. M., The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer. Oncology Reports 2002 9 1 193 198 2-s2.0-0036133928
27. Kuralay F., Tokgöz Z., Cömlekci A., Diagnostic usefulness of tumour marker levels in pleural effusions of malignant and benign origin. Clinica Chimica Acta 2000 300 1-2 43 55 2-s2.0-0033839468 10.1016/S0009-8981(00) 00302-8 (Pubitemid 30665773)
28. Hasegawa S., Koshikawa M., Takahashi I., Hachiya M., Furukawa T., Akashi M., Yoshida S., Saga T., Alterations in manganese, copper, and zinc contents, and intracellular status of the metal-containing superoxide dismutase in human mesothelioma cells. Journal of Trace Elements in Medicine and Biology 2008 22 3 248 255 2-s2.0-49849093893 10.1016/j.jtemb.2008.05.001
29. Shannahan J. H., Alzate O., Winnik W. M., Andrews D., Schladweiler M. C., Ghio A. J., Gavett S. H., Kodavanti U. P., Acute phase response, inflammation and metabolic syndrome biomarkers of Libby asbestos exposure. Toxicology and Applied Pharmacology 2012 260 2 105 114 2-s2.0-84859104883 10.1016/j.taap.2012. 02.006
30. Scanni A., Licciardello L., Trovato M., Tomirotti M., Biraghi M., Serum copper and ceruloplasmin levels in patients with neoplasias localized in the stomach, large intestine or lung. Tumori 1977 63 2 175 180 2-s2.0-0017653360 (Pubitemid 8136921)
31. Knekt P., Aromaa A., Maatela J., Rissanen A., Hakama M., Aaran R.-K., Nikkari T., Hakulinen T., Peto R., Teppo L., Serum ceruloplasmin and the risk of cancer in Finland. British Journal of Cancer 1992 65 2 292 296 2-s2.0-0026501971